companyNewsغير مصنف

UPDATE 1-Seattle Genetics’ cancer drug put on clinical hold after 4 deaths

Dec 27 (Reuters) – Seattle Genetics Inc said four
people had died in trials testing its experimental cancer drug,
prompting the U.S. Food and Drug Administration to impose a
clinical hold on several early-stage studies.

اظهر المزيد

مقالات ذات صلة

شاهد أيضاً
زر الذهاب إلى الأعلى